176 related articles for article (PubMed ID: 34344360)
1. Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy.
Truby LK; Regan JA; Giamberardino SN; Ilkayeva O; Bain J; Newgard CB; O'Connor CM; Felker GM; Kraus WE; McGarrah RW; Shah SH
Cardiovasc Diabetol; 2021 Aug; 20(1):161. PubMed ID: 34344360
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support.
Ahmad T; Kelly JP; McGarrah RW; Hellkamp AS; Fiuzat M; Testani JM; Wang TS; Verma A; Samsky MD; Donahue MP; Ilkayeva OR; Bowles DE; Patel CB; Milano CA; Rogers JG; Felker GM; O'Connor CM; Shah SH; Kraus WE
J Am Coll Cardiol; 2016 Jan; 67(3):291-9. PubMed ID: 26796394
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial.
Wang H; Anstrom K; Ilkayeva O; Muehlbauer MJ; Bain JR; McNulty S; Newgard CB; Kraus WE; Hernandez A; Felker GM; Redfield M; Shah SH
JAMA Cardiol; 2017 Aug; 2(8):896-901. PubMed ID: 28492915
[TBL] [Abstract][Full Text] [Related]
4. Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial.
Banks AZ; Mentz RJ; Stebbins A; Mikus CR; Schulte PJ; Fleg JL; Cooper LS; Leifer ES; Badenhop DT; Keteyian SJ; Piña IL; Kitzman DW; Fiuzat M; Whellan DJ; Kraus WE; O'Connor CM
J Card Fail; 2016 Jul; 22(7):485-91. PubMed ID: 26687984
[TBL] [Abstract][Full Text] [Related]
5. Effects of hybrid comprehensive telerehabilitation on cardiopulmonary capacity in heart failure patients depending on diabetes mellitus: subanalysis of the TELEREH-HF randomized clinical trial.
Główczyńska R; Piotrowicz E; Szalewska D; Piotrowicz R; Kowalik I; Pencina MJ; Zaręba W; Banach M; Orzechowski P; Pluta S; Irzmański R; Kalarus Z; Opolski G
Cardiovasc Diabetol; 2021 May; 20(1):106. PubMed ID: 33985509
[TBL] [Abstract][Full Text] [Related]
6. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
[TBL] [Abstract][Full Text] [Related]
7. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.
Ambrosy AP; Bhatt AS; Stebbins AL; Wruck LM; Fudim M; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Mentz RJ
Am Heart J; 2018 May; 199():97-104. PubMed ID: 29754673
[TBL] [Abstract][Full Text] [Related]
8. Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.
Felker GM; Fiuzat M; Thompson V; Shaw LK; Neely ML; Adams KF; Whellan DJ; Donahue MP; Ahmad T; Kitzman DW; Piña IL; Zannad F; Kraus WE; O'Connor CM
Circ Heart Fail; 2013 Nov; 6(6):1172-9. PubMed ID: 24103327
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.
Dauriz M; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP;
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679559
[TBL] [Abstract][Full Text] [Related]
10. Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure.
Tsuda M; Fukushima A; Matsumoto J; Takada S; Kakutani N; Nambu H; Yamanashi K; Furihata T; Yokota T; Okita K; Kinugawa S; Anzai T
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):844-859. PubMed ID: 30168279
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).
Mentz RJ; Schulte PJ; Fleg JL; Fiuzat M; Kraus WE; Piña IL; Keteyian SJ; Kitzman DW; Whellan DJ; Ellis SJ; O'Connor CM
Am Heart J; 2013 Feb; 165(2):193-9. PubMed ID: 23351822
[TBL] [Abstract][Full Text] [Related]
12. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
[TBL] [Abstract][Full Text] [Related]
13. Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.
Ruiz M; Labarthe F; Fortier A; Bouchard B; Thompson Legault J; Bolduc V; Rigal O; Chen J; Ducharme A; Crawford PA; Tardif JC; Des Rosiers C
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H768-H781. PubMed ID: 28710072
[TBL] [Abstract][Full Text] [Related]
14. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
[TBL] [Abstract][Full Text] [Related]
15. Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients.
Lanfear DE; Gibbs JJ; Li J; She R; Petucci C; Culver JA; Tang WHW; Pinto YM; Williams LK; Sabbah HN; Gardell SJ
JACC Heart Fail; 2017 Nov; 5(11):823-832. PubMed ID: 29096792
[TBL] [Abstract][Full Text] [Related]
16. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
[TBL] [Abstract][Full Text] [Related]
17. Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction.
Tromp J; Lim SL; Tay WT; Teng TK; Chandramouli C; Ouwerkerk W; Wander GS; Sawhney JPS; Yap J; MacDonald MR; Ling LH; Sattar N; McMurray JJV; Richards AM; Anand I; Lam CSP;
Diabetes Care; 2019 Sep; 42(9):1792-1799. PubMed ID: 31292141
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF.
Selvaraj S; Fu Z; Jones P; Kwee LC; Windsor SL; Ilkayeva O; Newgard CB; Margulies KB; Husain M; Inzucchi SE; McGuire DK; Pitt B; Scirica BM; Lanfear DE; Nassif ME; Javaheri A; Mentz RJ; Kosiborod MN; Shah SH;
Circulation; 2022 Sep; 146(11):808-818. PubMed ID: 35603596
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Metabolomics Reveals Heart Failure With Midrange Ejection Fraction as a Distinct Phenotype of Heart Failure.
Zhao H; Shui B; Zhao Q; Hu Z; Shu Q; Su M; Zhang Y; Ni Y
Can J Cardiol; 2021 Feb; 37(2):300-309. PubMed ID: 32795449
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial Factors, Exercise Adherence, and Outcomes in Heart Failure Patients: Insights From Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION).
Cooper LB; Mentz RJ; Sun JL; Schulte PJ; Fleg JL; Cooper LS; Piña IL; Leifer ES; Kraus WE; Whellan DJ; Keteyian SJ; O'Connor CM
Circ Heart Fail; 2015 Nov; 8(6):1044-51. PubMed ID: 26578668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
